Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical Report